Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

11.40 -0.31 (-2.60%)
Streaming Delayed Price Updated: 1:22 PM EDT, Jul 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,425,899
Open 11.82
Bid (Size) 11.40 (200)
Ask (Size) 11.41 (600)
Prev. Close 11.71
Today's Range 11.01 - 11.89
52wk Range 3.920 - 15.40
Shares Outstanding 41,695,335
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Eli Lilly Is Acquiring a Psychedelic Medicine Biotech. Here's What You Need to Know. ↗
Lilly's purchase of AtaiBeckley is yet another strategic move in its bid to diversify its pipeline. 
Via The Motley Fool
News headline image
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates
EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:CMPS),(NASDAQ:ATAI),(NYSE:JNJ),(NYSE:LLY) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence

Performance

YTD
+74.1%
+74.1%
1 Month
-9.8%
-9.8%
3 Month
+24.6%
+24.6%
6 Month
+60.0%
+60.0%
1 Year
+146.9%
+146.9%

More News

Read More
News headline image
Compass Pathways Announces Publication of Post-Hoc Analysis Demonstrating Distinction of COMP360 Trial Monitoring & Support from Psychotherapy
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Eyes 2027 Launch as Psilocybin Depression Data Holds Up ↗
Via MarketBeat
Topics Cannabis Government
News headline image
Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Compass Pathfinder Limited
Via Business Wire
News headline image
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
Via FinancialNewsMedia
News headline image
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
From MarketNewsUpdates.com
Via GlobeNewswire
News headline image
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Elects Kathleen Tregoning to Board of Directors
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 2026
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Eyes Q4 FDA Filing for Psilocybin Depression Drug After Phase 3 Wins ↗
Via MarketBeat
Topics Cannabis Government
News headline image
Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass (CMPS) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Compass Pathways Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Cannabis Earnings Government
News headline image
Compass Pathways Announces First Quarter 2026 Financial Results and Business Highlights
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways to Announce First Quarter 2026 Financial Results on May 13, 2026
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Compass Pathfinder Limited
Via Business Wire
News headline image
These 3 Psychedelic Stocks Activated After Trump's Executive Order ↗
Via MarketBeat
Topics Government
News headline image
Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher
From Compass Pathfinder Limited
Via Business Wire
News headline image
Trump Backs Psychedelics. Here's 1 Company Investors Need to Know About ↗
Via The Motley Fool
Topics Government
News headline image
Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments
From Compass Pathfinder Limited
Via Business Wire
After Fifteen Years, Tim Cook Steps Down, Wall Street Steps Back, Oil Steps Up ↗
Via Chartmill
News headline image
Small-Cap Medical Stocks: ATAI, CMPS, NDRA, PBM in Focus as U.S. Policy Accelerates Psychedelic Research
Via AB Newswire
News headline image
This 4/20, Wall Street Is Betting on More Than Marijuana ↗
Via MarketBeat

Frequently Asked Questions

Is COMPASS Pathways Plc - American Depository Shares publicly traded?
Yes, COMPASS Pathways Plc - American Depository Shares is publicly traded.
What exchange does COMPASS Pathways Plc - American Depository Shares trade on?
COMPASS Pathways Plc - American Depository Shares trades on the Nasdaq Stock Market
What is the ticker symbol for COMPASS Pathways Plc - American Depository Shares?
The ticker symbol for COMPASS Pathways Plc - American Depository Shares is CMPS on the Nasdaq Stock Market
What is the current price of COMPASS Pathways Plc - American Depository Shares?
The current price of COMPASS Pathways Plc - American Depository Shares is 11.40
When was COMPASS Pathways Plc - American Depository Shares last traded?
The last trade of COMPASS Pathways Plc - American Depository Shares was at 07/24/26 01:22 PM ET
What is the market capitalization of COMPASS Pathways Plc - American Depository Shares?
The market capitalization of COMPASS Pathways Plc - American Depository Shares is 475.54M
How many shares of COMPASS Pathways Plc - American Depository Shares are outstanding?
COMPASS Pathways Plc - American Depository Shares has 476M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.